Identification of PP2A as a novel interactor and regulator of TRIP-Br1

Zhi Jiang Zang1, Lakshman Gunaratnam, Jit Kong Cheong

  • 1Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Cellular Signalling
|October 23, 2008
PubMed

Insights

The serine/threonine protein phosphatase 2A (PP2A) Balpha subunit interacts with TRIP-Br1, a proto-oncogene involved in cell cycle regulation. This interaction influences TRIP-Br1 protein levels and phosphorylation, suggesting a novel regulatory mechanism.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • TRIP-Br proteins are transcriptional coregulators crucial for E2F-mediated cell cycle progression.
  • TRIP-Br1, a member of this family, is recognized as a proto-oncogene implicated in cancer development.

Purpose of the Study:

  • To identify novel interacting partners of TRIP-Br1.
  • To elucidate the functional relationship between TRIP-Br1 and protein phosphatase 2A (PP2A).

Main Methods:

  • Affinity binding assay coupled with mass spectrometry to identify TRIP-Br1 interactors.
  • GST-TRIP-Br1 fusion protein assays and co-immunoprecipitation to confirm in vitro and in vivo interactions.
  • Immunofluorescence microscopy for subcellular localization studies.
  • Functional assays involving PP2A inhibition (okadaic acid) and silencing (siRNA), and overexpression studies.

Main Results:

  • The Balpha regulatory subunit of PP2A was identified as a novel interactor of TRIP-Br1.
  • TRIP-Br1 and PP2A-Balpha colocalize in the cytoplasm, and TRIP-Br1 is serine-phosphorylated.
  • PP2A inhibition decreases total TRIP-Br1 but increases its serine-phosphorylated form; PP2A overexpression enhances TRIP-Br1 levels and co-activates E2F1/DP1 transcription.

Conclusions:

  • The association between PP2A-ABalphaC holoenzyme and TRIP-Br1 represents a novel mechanism for regulating TRIP-Br1 proto-oncogene levels in mammalian cells.
  • PP2A plays a critical role in modulating TRIP-Br1 protein stability and phosphorylation status, impacting its oncogenic function.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...